There is only one vaccine trial to start in the month of April

New candidate vaccine for 2019-nCov

Name of Vaccine



Clinical trial


NIAID &  ModernaTX, Inc


This is a Phase I study

 Is a novel lipid nanoparticle (LNP)-encapsulated mRNA-based vaccine that encodes for a full-length, prefusion stabilized spike (S) protein of 2019-novel coronavirus (nCoV). Identifier: NCT04283461